VANGUARD GROUP INC 13D and 13G filings for Arcturus Therapeutics Holdings Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-26 3:56 pm Sale | 2026-03-13 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | VANGUARD GROUP INC | 0 0.000% | -1,810,165 (Position Closed) | Filing |
| 2025-07-29 12:05 pm Purchase | 2025-06-30 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | VANGUARD GROUP INC | 1,810,165 6.670% | 351,785 (+24.12%) | Filing |
| 2024-02-13 4:59 pm Purchase | 2023-12-29 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | VANGUARD GROUP INC | 1,458,380 5.460% | 7,955 (+0.55%) | Filing |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | VANGUARD GROUP INC | 1,450,425 5.460% | 1,450,425 (New Position) | Filing |